Compare RGEN & FIGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RGEN | FIGR |
|---|---|---|
| Founded | 1981 | 2018 |
| Country | United States | United States |
| Employees | N/A | 602 |
| Industry | Medical/Dental Instruments | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.6B | 7.0B |
| IPO Year | 1995 | N/A |
| Metric | RGEN | FIGR |
|---|---|---|
| Price | $124.05 | $35.17 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 9 |
| Target Price | ★ $167.67 | $53.22 |
| AVG Volume (30 Days) | 1.3M | ★ 3.8M |
| Earning Date | 05-05-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 286.96 | N/A |
| EPS | ★ 0.15 | N/A |
| Revenue | ★ $141,236,000.00 | N/A |
| Revenue This Year | $14.30 | $69.23 |
| Revenue Next Year | $14.52 | $24.25 |
| P/E Ratio | $824.80 | ★ $134.36 |
| Revenue Growth | ★ 35.10 | N/A |
| 52 Week Low | $100.99 | $25.01 |
| 52 Week High | $175.77 | $78.00 |
| Indicator | RGEN | FIGR |
|---|---|---|
| Relative Strength Index (RSI) | 59.18 | 46.60 |
| Support Level | $121.25 | $31.68 |
| Resistance Level | $129.77 | $36.22 |
| Average True Range (ATR) | 6.49 | 3.30 |
| MACD | 1.57 | -0.57 |
| Stochastic Oscillator | 88.42 | 19.93 |
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.
Figure Technology Solutions Inc is building the future of capital markets with blockchain technology. proprietary technology powers next-generation lending, trading, and investing activities in areas such as consumer credit and digital assets. Its use of the blockchain ledger allows them to serve their end customers, improve speed and efficiency, and enhance standardization and liquidity. The Company operates as a single operating and reportable segment. The company's geographical operations is within the USA, with the majority of revenue from California.